• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
CI Investment Grade Bond ETF
Data I/O Corporation - Common Stock
Ping An Biomedical Co., Ltd. - Class A Ordinary Shares
SPDR Portfolio S&P 500 ETF
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sigilon Therapeutics, Inc. - Common Stock (NQ:SGTX)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 10, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 21.95 (1)
Ask (Size) 23.18 (1)
Prev. Close 22.47
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 2,514,498
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Why These 3 Large Caps Are Bucking the August Slump
August 22, 2023
The three largest S&P 500 outperformers of August are tacking on gains in a weak market, making them intriguing momentum plays to watch for the rest of 2023. 
Via MarketBeat
Topics Economy Stocks
News headline image
Over $25M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying ↗
August 15, 2023
Although U.S. stocks closed mostly higher on Monday, there were a few notable insider trades. 
Via Benzinga

Performance

More News

Read More
News headline image
Eli Lilly To Report Q2 Earnings: What's In The Cards? ↗
August 05, 2023
Via Talk Markets
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: American Equity Investment Life Holding Company (NYSE – AEL), Amedisys, Inc. (Nasdaq – AMED), Sigilon Therapeutics, Inc (Nasdaq – SGTX)
July 25, 2023
From Brodsky & Smith LLC
Via GlobeNewswire
Sigilon Therapeutics Inc. (NASDAQ: SGTX) Near the Top of Equities by Percentage Gain on 6/29
June 29, 2023
Via Investor Brand Network
News headline image
Health Care Company Eli Lilly Announces Acquisition of Sigilon Therapeutics ↗
June 29, 2023
Via Benzinga
News headline image
SIGILON THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sigilon Therapeutics, Inc. - SGTX
July 21, 2023
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: American Equity Investment Life Holding Company (NYSE – AEL), Amedisys, Inc. (Nasdaq – AMED), Sigilon Therapeutics, Inc (Nasdaq – SGTX)
July 20, 2023
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Sigilon Therapeutics, Inc (Nasdaq – SGTX)
July 12, 2023
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
SIGILON THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sigilon Therapeutics, Inc. - SGTX
July 03, 2023
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Stock Market Rally Roars Back Toward Highs; Carnival, Delta, Micron, Nvidia In Focus: Weekly Review ↗
June 30, 2023
Via Investor's Business Daily
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2023 ↗
June 30, 2023
Via Benzinga
News headline image
Tesla, Nike, Sigilon Therapeutics Among Top Trending Stocks Today ↗
June 29, 2023
Via Benzinga
News headline image
Nasdaq Moves Lower; Acuity Brands Earnings Top Estimates ↗
June 29, 2023
Via Benzinga
News headline image
Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
June 29, 2023
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
June 29, 2023
Via Benzinga
News headline image
Crude Oil Edges Higher; McCormick Posts Upbeat Earnings ↗
June 29, 2023
Via Benzinga
News headline image
Dow Rises Over 100 Points; US GDP Grows 2% In Q1 ↗
June 29, 2023
Via Benzinga
News headline image
Sigilon Therapeutics Scores Eli Lilly Buyout And Skyrockets More Than 500% ↗
June 29, 2023
Via Investor's Business Daily
News headline image
Sigilon Therapeutics Shares Are Shooting Higher Today - What's Going On ↗
June 29, 2023
Via Benzinga
News headline image
Why Is Cormedix (CRMD) Stock Down 23% Today? ↗
June 29, 2023
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
June 29, 2023
Via Benzinga
News headline image
Why Is BioXcel Therapeutics (BTAI) Stock Down 57% Today? ↗
June 29, 2023
Via InvestorPlace
News headline image
SGTX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Sigilon Therapeutics, Inc. Is Fair to Shareholders
June 29, 2023
From Halper Sadeh LLC
Via Business Wire
News headline image
Why Is Eco Wave Power Global (WAVE) Stock Up 58% Today? ↗
June 29, 2023
Via InvestorPlace

Frequently Asked Questions

Is Sigilon Therapeutics, Inc. - Common Stock publicly traded?
Yes, Sigilon Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Sigilon Therapeutics, Inc. - Common Stock trade on?
Sigilon Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sigilon Therapeutics, Inc. - Common Stock?
The ticker symbol for Sigilon Therapeutics, Inc. - Common Stock is SGTX on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap